Arsene Mekinian: Immunomodulatory Therapy Shows Promise in Recurrent Pregnancy Loss with MPFD
Arsene Mekinian, Professor of Medicine, Internal Medicine at Sorbonne University, President of the Armenian Health NGO, shared a post on LinkedIn about a paper published in Journal of Reproductive Immunology:
“Maladie placentaire inflammatoire dont MPFD : une des rares premières données sur traitement potentiel
Abisror N, Hermine AC, Dolenc B, Ezsto ML, Campagne J, Mekinian A. Successful live birth following immunomodulatory therapy in a patient with multiple recurrent pregnancy loss and massive perivillous fibrinoid deposition. J Reprod Immunol. 2026 Jun 29;176:104931. doi: 10.1016/j.jri.2026.104931. Epub ahead of print. PMID: 42392016.”
Title: Successful live birth following immunomodulatory therapy in a patient with multiple recurrent pregnancy loss and massive perivillous fibrinoid deposition
Authors: Noémie Abisror, Aurore Coulomb Hermine, Bérangère Dolenc, Marie-Laure Ezsto, Julien Campagne, Arsene Mekinian
Stay updated on all scientific advances in the field of fertility with Fertility News.
-
Jul 6, 2026, 15:41ISUOG World Congress 2026 – London, UK – ISUOG
-
Jul 6, 2026, 15:35Jackson Kirkman-Brown: A Great Monday at ESHRE 2026 as Andrology and Male Health Take Centre Stage
-
Jul 6, 2026, 15:19Emre Göksan Pabuçcu: Happy to Share That Our Meta-Analysis Was Presented at the 42nd ESHRE Annual Meeting
-
Jul 6, 2026, 14:54Mental Health Matters in PMOS – PCOS Awareness Association
-
Jul 6, 2026, 14:51Why a GnRH Agonist Trigger Can Still Cause OHSS – Fertility Plus
-
Jul 6, 2026, 14:47Trishdeep Grewal: Hybrid CPAM with Spontaneous Prenatal Regression
-
Jul 5, 2026, 17:08The Opening Ceremony Has Started With the ESHRE Chair Anis Feki’s Welcome – ESHRE SIG Fertility Preservation
-
Jul 5, 2026, 17:04Every Parent Wants the Best Start for Their Baby – WHO
-
Jul 5, 2026, 16:53Eve Feinberg: Looking Forward to Recording Fertility and Sterility On Air at ESHRE 2026